Technology area: Medical Devices & Mechanical Engineering
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Pirouette Pharma Inc. has 1 pending office action in the Medical Devices & Mechanical Engineering technology area. The prosecution is handled by 1 distinct examiner, SHAH, NILAY J, in a distinct art unit. SHAH, NILAY J is the busiest examiner for the portfolio, with 1 pending action currently assigned.
This represents a highly focused prosecution effort where all current activity is concentrated under one individual and one art unit. Practitioners should focus their strategy for the pending office action on the specific tendencies of SHAH, NILAY J. The presence of a single art unit suggests a specific technical focus within the Medical Devices & Mechanical Engineering field. This centralized structure provides a clear path for the resolution of the 1 pending action. The alignment of the busiest examiner's workload with the total pending actions ensures a clear point of contact within the patent office. This concentration allows for a highly targeted approach to the pending office action. The lack of multiple examiners or art units minimizes the complexity of managing the company's current patent interests. By focusing on the individual review style of the assigned examiner, the company can better anticipate procedural hurdles.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHAH, NILAY J | 1 | 76.3% | +46.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18658491 | COMPACT AUTO-INJECTOR | SHAH, NILAY J | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18658491 | COMPACT AUTO-INJECTOR | SHAH, NILAY J | — |
| Art Unit | Apps |
|---|---|
| 3783 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18658491 | COMPACT AUTO-INJECTOR | SHAH, NILAY J | 3783 | §102§103 | Non-Final OA | — | Pending | May 08, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialPirouette Pharma Inc. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Nilay J Shah has the most, with 1 of Pirouette Pharma Inc.'s pending office actions.
Mostly Medical Devices & Mechanical Engineering (USPTO Tech Center 3700), based on where its pending office actions are examined.
